Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT03993379 |
| Consolidated Lead Sponsor | CytomX Therapeutics |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 3 participants (ACTUAL) |
| Registered Start Date | 2019-11-20 |
| WhyStopped Classification | Strategic / Business / Sponsor Decision |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| City of Hope National Medical Center | Duarte, CA | Open Hospital Dossier -> |
| University of Chicago Medicine | Chicago, IL | Open Hospital Dossier -> |
| Norton Cancer Institute | Louisville, KY | Open Hospital Dossier -> |
| Dana-Farber Cancer Institute | Boston, MA | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.